Meet ChemDiv at EFMC-ISMC’18 International Symposium on Medicinal Chemistry

Title: Meet ChemDiv at EFMC-ISMC’18 International Symposium on Medicinal Chemistry

Introduction:

ChemDiv, a leading global provider of discovery and early-stage research and development solutions, is excited to participate in the EFMC-ISMC’18 International Symposium on Medicinal Chemistry. In this blog, we will discuss the key points of the conference and highlight ChemDiv’s participation in the event including the products, services, and expertise they will be showcasing.

Key Points:

1. The EFMC-ISMC’18 International Symposium on Medicinal Chemistry:
   The EFMC-ISMC’18 International Symposium on Medicinal Chemistry is the leading European conference on medicinal chemistry. The conference is organized by the European Federation for Medicinal Chemistry (EFMC), and every two years, it convenes the greatest minds in drug discovery and development worldwide to discuss the latest breakthroughs and advances in the field.
2. ChemDiv’s Participation in the Conference:
   ChemDiv is a trusted partner of the pharmaceutical and biotech industries, offering a comprehensive range of discovery and early-stage research and development solutions. At the EFMC-ISMC’18 International Symposium on Medicinal Chemistry, ChemDiv will showcase their capabilities and expertise in the field of medicinal chemistry, highlighting their diverse range of products and services and their impact on drug discovery and development.
3. Products and Services:
   ChemDiv’s participation in the conference would feature their extensive line of compound libraries, which includes more than 1.7 million compounds. The company’s library has been widely used by researchers in drug discovery programs, providing access to lead-like scaffolds and accelerating the discovery of new drug candidates. In addition to libraries, ChemDiv will also showcase their custom synthesis capabilities and existing drug discovery and development programs.
4. Expertise:
   With over 25 years of experience in the pharmaceutical and biotech industry, ChemDiv has built a prestigious reputation based on their scientific expertise and commitment to innovative research. Their team of experts will be in attendance at the conference, ready to discuss new opportunities and collaborations related to medicinal chemistry and drug discovery.
5. The Impact on Drug Discovery and Development:
   ChemDiv’s participation in the EFMC-ISMC’18 International Symposium on Medicinal Chemistry has significant implications for drug discovery and development. Medicinal chemistry offers an efficient and innovative approach to drug discovery, enabling researchers to access previously inaccessible compounds more quickly and cost-effectively. By showcasing their expertise in this field, ChemDiv is contributing to the advancement of drug discovery and ultimately leading to novel treatments for many diseases.

Conclusion:

The EFMC-ISMC’18 International Symposium on Medicinal Chemistry provides an excellent opportunity for researchers and practitioners to explore the latest advances in the field of medicinal chemistry and their impact on drug discovery and development. ChemDiv’s participation in the event, highlighting their expertise, products, and services related to medicinal chemistry, underscores their commitment to innovation and partnership in advancing healthcare. By collaborating with ChemDiv, researchers can access cutting-edge solutions and accelerate their drug discovery programs, driving the development of novel treatments for a range of diseases.